MX2008002158A - Derivados de azinil-3-sulfonilindazol como ligandos de 5-hidroxitriptamina-6. - Google Patents
Derivados de azinil-3-sulfonilindazol como ligandos de 5-hidroxitriptamina-6.Info
- Publication number
- MX2008002158A MX2008002158A MX2008002158A MX2008002158A MX2008002158A MX 2008002158 A MX2008002158 A MX 2008002158A MX 2008002158 A MX2008002158 A MX 2008002158A MX 2008002158 A MX2008002158 A MX 2008002158A MX 2008002158 A MX2008002158 A MX 2008002158A
- Authority
- MX
- Mexico
- Prior art keywords
- azinyl
- hydroxytryptamine
- ligands
- sulfonylindazole
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La presente invencion suministra un compuesto de formula I y el uso del mismo para el tratamiento de un desorden del sistema nervioso central relacionado con o afectado por el receptor 5-HT6. (ver formula (I)).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70831705P | 2005-08-15 | 2005-08-15 | |
PCT/US2006/030837 WO2007032833A1 (en) | 2005-08-15 | 2006-08-08 | Azinyl-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2008002158A true MX2008002158A (es) | 2008-04-19 |
Family
ID=37315656
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2008002158A MX2008002158A (es) | 2005-08-15 | 2006-08-08 | Derivados de azinil-3-sulfonilindazol como ligandos de 5-hidroxitriptamina-6. |
Country Status (21)
Country | Link |
---|---|
US (1) | US7790751B2 (es) |
EP (1) | EP1915348A1 (es) |
JP (1) | JP2009504738A (es) |
KR (1) | KR20080034497A (es) |
CN (1) | CN101291913A (es) |
AR (1) | AR056459A1 (es) |
AU (1) | AU2006291414A1 (es) |
BR (1) | BRPI0614341A2 (es) |
CA (1) | CA2619309A1 (es) |
CR (1) | CR9733A (es) |
EC (1) | ECSP088176A (es) |
GT (1) | GT200600374A (es) |
IL (1) | IL189416A0 (es) |
MX (1) | MX2008002158A (es) |
NO (1) | NO20080553L (es) |
PE (1) | PE20070373A1 (es) |
RU (1) | RU2008103700A (es) |
SV (1) | SV2008002653A (es) |
TW (1) | TW200800913A (es) |
WO (1) | WO2007032833A1 (es) |
ZA (1) | ZA200801524B (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101282938A (zh) * | 2005-08-15 | 2008-10-08 | 惠氏公司 | 作为5-羟色胺-6配体的经取代3-磺酰基吲唑衍生物 |
AR063469A1 (es) * | 2006-07-14 | 2009-01-28 | Ranbaxy Lab Ltd | Formas polimorficas de ácido (3r,5r)-7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroximetilfenilamino)carbonil]-pirrol-1-il]-3, 5-dihidroxi-heptanoico, sal hemicalcio, metodos de preparacion de las mismas, una composicion farmaceutica que las comprende y su uso en el tratamiento de enfermedades |
CA2667710A1 (en) * | 2006-11-09 | 2008-05-15 | F. Hoffmann-La Roche Ag | Arylsulfonyl pyrrolidines as 5-ht6 inhibitors |
EP2158195A1 (en) | 2007-05-15 | 2010-03-03 | Wyeth LLC | 5- (aminoazacyclyl) -3-sulfonyl-lh- indazoles as 5-hydroxytryptamine- 6 ligands for the treatment of cns disorders |
US20090012308A1 (en) * | 2007-06-13 | 2009-01-08 | Wyeth | Process for the manufacture of benzylsulfonylarenes |
WO2010124042A2 (en) * | 2009-04-23 | 2010-10-28 | Abbott Laboratories | Modulators of 5-ht receptors and methods of use thereof |
US8518933B2 (en) * | 2009-04-23 | 2013-08-27 | Abbvie Inc. | Modulators of 5-HT receptors and methods of use thereof |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1028946A1 (en) | 1997-11-04 | 2000-08-23 | Pfizer Products Inc. | Indazole bioisostere replacement of catechol in therapeutically active compounds |
CA2378047A1 (en) | 1999-07-15 | 2001-01-25 | Methvin Isaac | Heterocyclic compounds for the treatment of migraine |
EA200300717A1 (ru) * | 2000-12-22 | 2003-12-25 | Уайт | Гетероциклилиндазольные и -азаиндазольные соединения в качестве 5-гидрокситриптамин-6-лигандов |
CA2444095A1 (en) | 2001-04-20 | 2002-10-31 | Wyeth | Heterocyclyloxy-, -thioxy- and -aminobenzazole derivatives as 5-hydroxytryptamine-6 ligands |
EA200301143A1 (ru) * | 2001-04-20 | 2004-02-26 | Уайт | Производные гетероциклилалкокси-, алкилтио- и -алкиламинобензазола в качестве лигандов 5-гидрокситриптамина-6 |
JPWO2002100833A1 (ja) | 2001-06-12 | 2004-09-24 | 住友製薬株式会社 | Rhoキナーゼ阻害剤 |
US20050113283A1 (en) | 2002-01-18 | 2005-05-26 | David Solow-Cordero | Methods of treating conditions associated with an EDG-4 receptor |
TW200400177A (en) | 2002-06-04 | 2004-01-01 | Wyeth Corp | 1-(Aminoalkyl)-3-sulfonylindole and-indazole derivatives as 5-hydroxytryptamine-6 ligands |
JP4754821B2 (ja) | 2002-06-20 | 2011-08-24 | プロキシマゲン・リミテッド | 肥満症、ii型糖尿病およびcns障害の治療に有用な新規化合物 |
TW200401641A (en) | 2002-07-18 | 2004-02-01 | Wyeth Corp | 1-Heterocyclylalkyl-3-sulfonylindole or-indazole derivatives as 5-hydroxytryptamine-6 ligands |
TW200412945A (en) * | 2002-10-25 | 2004-08-01 | Upjohn Co | Quaternary ammonium compounds |
KR20050101551A (ko) | 2003-02-14 | 2005-10-24 | 와이어쓰 | 5-하이드록시트립타민-6 리간드로서의헤테로사이클릴-3-설포닐인다졸 |
CA2557268A1 (en) | 2004-02-27 | 2005-09-15 | F. Hoffmann-La Roche Ag | Indazole derivatives and pharmaceutical compositions containing them |
-
2006
- 2006-08-08 AU AU2006291414A patent/AU2006291414A1/en not_active Abandoned
- 2006-08-08 MX MX2008002158A patent/MX2008002158A/es unknown
- 2006-08-08 EP EP06800937A patent/EP1915348A1/en not_active Withdrawn
- 2006-08-08 WO PCT/US2006/030837 patent/WO2007032833A1/en active Application Filing
- 2006-08-08 JP JP2008526990A patent/JP2009504738A/ja not_active Withdrawn
- 2006-08-08 BR BRPI0614341-5A patent/BRPI0614341A2/pt not_active Application Discontinuation
- 2006-08-08 CN CNA2006800299549A patent/CN101291913A/zh active Pending
- 2006-08-08 CA CA002619309A patent/CA2619309A1/en not_active Abandoned
- 2006-08-08 KR KR1020087005479A patent/KR20080034497A/ko not_active Application Discontinuation
- 2006-08-08 RU RU2008103700/04A patent/RU2008103700A/ru not_active Application Discontinuation
- 2006-08-14 US US11/504,243 patent/US7790751B2/en not_active Expired - Fee Related
- 2006-08-14 TW TW095129788A patent/TW200800913A/zh unknown
- 2006-08-14 PE PE2006000985A patent/PE20070373A1/es not_active Application Discontinuation
- 2006-08-14 AR ARP060103550A patent/AR056459A1/es unknown
- 2006-08-14 GT GT200600374A patent/GT200600374A/es unknown
- 2006-08-14 SV SV2006002653A patent/SV2008002653A/es unknown
-
2008
- 2008-01-30 NO NO20080553A patent/NO20080553L/no not_active Application Discontinuation
- 2008-02-10 IL IL189416A patent/IL189416A0/en unknown
- 2008-02-12 EC EC2008008176A patent/ECSP088176A/es unknown
- 2008-02-14 ZA ZA200801524A patent/ZA200801524B/xx unknown
- 2008-02-15 CR CR9733A patent/CR9733A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
RU2008103700A (ru) | 2009-09-27 |
JP2009504738A (ja) | 2009-02-05 |
KR20080034497A (ko) | 2008-04-21 |
BRPI0614341A2 (pt) | 2011-03-29 |
ECSP088176A (es) | 2008-04-28 |
ZA200801524B (en) | 2010-04-28 |
CR9733A (es) | 2008-04-02 |
CN101291913A (zh) | 2008-10-22 |
TW200800913A (en) | 2008-01-01 |
AR056459A1 (es) | 2007-10-10 |
EP1915348A1 (en) | 2008-04-30 |
SV2008002653A (es) | 2008-04-11 |
AU2006291414A1 (en) | 2007-03-22 |
IL189416A0 (en) | 2008-06-05 |
GT200600374A (es) | 2007-03-29 |
WO2007032833A1 (en) | 2007-03-22 |
US7790751B2 (en) | 2010-09-07 |
PE20070373A1 (es) | 2007-04-04 |
NO20080553L (no) | 2008-04-23 |
US20070054896A1 (en) | 2007-03-08 |
CA2619309A1 (en) | 2007-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007142905A3 (en) | 1-sulfonylindazolylamine and -amide derivatives as 5-hydroxytryptamine-6 ligands | |
NO20050007L (no) | 1-Heterosyklylalkyl-3-sulfonylazaindol eller -azaindazolderivater som 5-hydroksytryptamin-6 ligander | |
NO20050014L (no) | 1-Heterosyklylalkyl-3-sulfonylindol eller -indazolderivater som 5-hydroksytryptamin-6 ligander | |
MX2009007075A (es) | Metodos de uso para analogos de ciclopamina. | |
EA200900048A1 (ru) | Новые карбонилированные (аза)циклогексаны в качестве лигандов d3 рецептора дофамина | |
TW200800958A (en) | N-substituted-azacyclylamines as histamine-3 antagonists | |
PL1979355T3 (pl) | Pochodne spiro imidazoli jako modulatory PPAR | |
TW200833686A (en) | Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-Met inhibitors | |
MX2010002899A (es) | Derivados de azaciclilisoquinolinona e isoindolinona como antagonistas de la histamina-3. | |
TNSN08373A1 (en) | Azolopyrimidines as inhibitors of cannabinoid 1 activity | |
MX2010002760A (es) | Derivados de isoquinolinilo e isoindolinilo como antagonistas de la histamina-3. | |
MX2009003645A (es) | Azaciclilaminas n-sustituidas como antagonistas de histamina-3. | |
MX2008013196A (es) | 5-amido-2-carboxiamida-indoles. | |
WO2007136668A3 (en) | N-benzoyl-and n-benzylpyrrolidin-3-ylamines as histamine-3 antagonists | |
MX2009006170A (es) | Compuestos y composiciones como inhibidores de cinasa. | |
MXPA06000701A (es) | Compuestos de sulfonildihidrobencimidazolona como ligandos de 5-hidroxitriptamina-6. | |
MX2008002158A (es) | Derivados de azinil-3-sulfonilindazol como ligandos de 5-hidroxitriptamina-6. | |
UA94053C2 (ru) | Замещенные производные 3-сульфонилиндазола в качестве лигандов гидрокситриптамина-6 | |
MX2008011576A (es) | Compuestos de imidazo[2,1-b]tiazol sustituidos y su uso para la produccion de farmacos. | |
MX2008013053A (es) | Derivados de dihidri[1,4]oxazino[2,3,4-hi]indazol-sustituidos como ligandos de 5-hidroxitriptamina-6. | |
UA106200C2 (uk) | Заміщені похідні оксіндолу та їхнє застосування для лікування захворювань, залежних від вазопресину | |
MY149973A (en) | 3-carboxypropyl-aminotetralin derivatives as mu opioid receptor antagonists | |
MXPA06000957A (es) | Compuestos de n-sulfonil heterociclopirrolilalquilamina como ligandos de 5-hidroxitriptamina-6. | |
TW200606148A (en) | Indolylalkylamine metabolites as 5-hydroxytryptamine-6 ligands | |
MXPA06000700A (es) | Compuestos de sulfonildihidroimidazopiridinona como ligandos de 5-hidroxitriptamina-6. |